Could Resveratrol be a Useful Drug for the Treatment of Malignant Hemopathies?

ISSN: 2212-3970 (Online)
ISSN: 1574-8928 (Print)

Volume 12, 4 Issues, 2017

Download PDF Flyer

Recent Patents on Anti-Cancer Drug Discovery

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 35th of 254 in Pharmacology & Pharmacy
  • 46th of 211 in Oncology

Submit Abstracts Online Submit Manuscripts Online

Khurshid Zaman
Bentham Science Publishers

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.533
5 - Year: 2.638

Could Resveratrol be a Useful Drug for the Treatment of Malignant Hemopathies?

Recent Patents on Anti-Cancer Drug Discovery, 9(3): 340-353.

Author(s): Romeo G Mihaila.

Affiliation: Faculty of Medicine, "Lucian Blaga" University of Sibiu, str Lucian Blaga, nr 2A, Sibiu, 550169 Sibiu, Romania.


Resveratrol is a poly-phenol with many beneficial effects: not only as an antioxidant, anti-inflammatory, and antiatherogenic agent, as well as a platelet aggregation inhibitor, but also as an antiproliferative and proapoptotic factor in various types of cancers. There are reviews about the mechanisms responsible for its effects in leukemia and lymphomas, emphasizing the chemosensitizing role of resveratrol, which allows overcoming the multidrug resistance of cancers. The action of resveratrol occurs preferentially on leukemic cells, and not on the normal ones. In addition, it is one of the few drugs that act on leukemic stem cells. If experimental results are promising, its application in humans encounters some difficulties. The paper presents the causes of its low bioavailability, as well as recent patents that allow improvement of its bioavailability, development of new extraction procedures, obtaining new formulae, and associating resveratrol with other drugs in order to increase its effects. These patents allow optimizing its effects in order to obtain an adjuvant agent for treatment of oncohematological disorders.


Antioxidant, apoptosis, leukemia, lymphoma, minimal residual disease, multidrug resistance, proliferation, resveratrol.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 9
Issue Number: 3
First Page: 340
Last Page: 353
Page Count: 14
DOI: 10.2174/1574892809666140327161242
Price: $100

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science